Advertisement

Topics

Multigioco Adds Up to 180 Sports Bet Centric Online Gaming Locations

20:00 EDT 9 Aug 2015 | Globe Newswire

NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Empire Global Corp. (OTCQB:EMGL) is pleased to announce that through its wholly owned subsidiary Multigioco Srl., it has signed under contract up to 180 additional online web-shop gaming arcades situated throughout the highest grossing gaming regions in Italy. The locations currently generate largely sports betting revenue and have approximately 2,000 online gaming accounts.

The deal expands our online footprint to over 1000 web-shop locations and approximately 25,000 gaming accounts while our online gross gaming revenue is projected to increase to approximately 100 million euro annually with improved margins. The Company expects all locations to be integrated under our Multigioco online license and flagged with our originalbet.it branding by the end of September 2015.

"The acquisition of these prominent locations is a major stepping stone in our strategy for the 2016 license tender in Italy and is a great result for expanding the New Gioco and Multigioco brand in the market," remarked Company President, Alessandro Marcelli.

"We are absolutely delighted with this considerable accomplishment by our management team," stated Michele Ciavarella, CEO of the Company, "the transaction brings us steps closer to our goal of meeting the criteria for an exchange listing in the near future."

About Empire

Empire Global Corp. is a company focused on developing world-class products and services in the regulated global online gambling industry with specialization in the online sports betting vertical. Our vision is to develop our business through strategic mergers and acquisitions and reorganization of existing licensed operators in geographically diversified jurisdictions. We seek to create long-term value for our investors and positive economic influence with the companies and the communities we invest in through our commitment to responsible gaming and the clients we serve. Additional information is available on our website at www.emglcorp.com.

This Press Release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "forecast," "plans," "intends," "potential" and similar expressions. These statements reflect the company's current beliefs and are based upon currently available information. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements.

Factors which may cause such differences include the company's ability to complete additional acquisitions, expand our distribution, increase our client base and other risks disclosed in the Company's SEC filings. The company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information covered in this press release, including such forward-looking statements.

CONTACT: Michele Ciavarella, B.Sc.
         Chairman and CEO
         ceo.emgl@emglcorp.com

Empire Global logo

NEXT ARTICLE

More From BioPortfolio on "Multigioco Adds Up to 180 Sports Bet Centric Online Gaming Locations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...